Dr. Nadine Abi-Jaoudeh, MD

Dr. Abi-Jaoudeh practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Abi-Jaoudeh's NPI, 1235337627, was assigned on July 6, 2007. Dr. Abi-Jaoudeh graduated from University of Montreal Faculty of Medicine in 2002. Dr. Abi-Jaoudeh holds Virginia license 0101241253.

Dr. Abi-Jaoudeh's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Abi-Jaoudeh's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Department of Radiological Sciences. Dmand AI also links Dr. Abi-Jaoudeh to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abi-Jaoudeh practices. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Abi-Jaoudeh's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Abi-Jaoudeh is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Abi-Jaoudeh's licenses on file in 5 states: Virginia, California, Florida, Maryland and District of Columbia.

CMS data shows 508 Medicare services from Dr. Abi-Jaoudeh across 14 procedure codes in 2024, for 103 Medicare patients. Medicare paid $42,951 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 103 Medicare patients who saw Dr. Abi-Jaoudeh in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 49% are also on Medicaid. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abi-Jaoudeh's median patient age at 63, with 48% women.

In 2024, Dr. Abi-Jaoudeh wrote 35 Medicare Part D claims for 17 patients. 94% of them were for generic drugs.

Dr. Abi-Jaoudeh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abi-Jaoudeh as offering telehealth.

Dmand AI links 52 papers to Dr. Abi-Jaoudeh, published from 2011 to 2025. 2022 was the busiest year, with 5. The most frequent topics are Liver Neoplasms, Radiography, Interventional and Embolization, Therapeutic. Dr. Abi-Jaoudeh has published most often in J Vasc Interv Radiol. Dr. Abi-Jaoudeh's most frequent co-authors are Farshid Dayyani, MD, PhD, Aradhana M. Venkatesan, MD and Alexander Huynh Lam.

Dmand AI links Dr. Abi-Jaoudeh to 2 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Carcinoma, Hepatocellular, Disease Progression and Liver Neoplasms. Teclison Ltd. sponsors the most, 2.

CMS Open Payments shows 206 general payments to Dr. Abi-Jaoudeh from 28 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 62% of the total. Boston Scientific Corporation paid the most, $22,749.

Dr. Abi-Jaoudeh graduated from University of Montreal Faculty of Medicine in 2002. Dr. Abi-Jaoudeh is a member of SIR.

Dr. Abi-Jaoudeh is in network with 8 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.